Cara Therapeutics Inc
General ticker "CARA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $16.0M
Cara Therapeutics Inc does not follow the US Stock Market performance with the rate: -26.8%.
Estimated limits based on current volatility of 19.2%: low 0.28$, high 0.42$
Factors to consider:
- Current price 37.8% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.68$, 1.83$]
- 2024-12-30 to 2025-12-30 estimated range: [0.84$, 2.01$]
Financial Metrics affecting the CARA estimates:
- Negative: Non-GAAP EPS, $ of -2.18 <= 0.10
- Negative: Operating profit margin, % of -85.28 <= 1.03
- Negative: Operating cash flow per share per price, % of -63.68 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
- Negative: Inventory ratio change, % of 6.47 > 1.08
Short-term CARA quotes
Long-term CARA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $23.03MM | $41.87MM | $20.97MM |
| Operating Expenses | $112.11MM | $129.40MM | $142.46MM |
| Operating Income | $-89.08MM | $-87.53MM | $-121.50MM |
| Non-Operating Income | $0.64MM | $2.06MM | $2.98MM |
| Interest Expense | $0.00MM | $0.00MM | $0.60MM |
| R&D Expense | $82.70MM | $91.88MM | $108.51MM |
| Income(Loss) | $-88.44MM | $-85.47MM | $-118.51MM |
| Profit(Loss) | $-88.44MM | $-85.47MM | $-118.51MM |
| Stockholders Equity | $227.52MM | $158.78MM | $57.09MM |
| Inventory | $2.58MM | $2.38MM | $2.82MM |
| Assets | $247.06MM | $182.24MM | $125.84MM |
| Operating Cash Flow | $-60.09MM | $-78.73MM | $-92.08MM |
| Capital expenditure | $0.04MM | $0.04MM | $2.38MM |
| Investing Cash Flow | $-4.75MM | $128.71MM | $43.46MM |
| Financing Cash Flow | $46.61MM | $0.31MM | $38.15MM |
| Earnings Per Share* | $-1.74 | $-1.55 | $-2.19 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.